Loading clinical trials...

Human Salivary Gland Disposition of Alda-341 in Patients Undergoing Salivary Gland Surgery | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDEARLY Phase 1NCT04296266

Human Salivary Gland Disposition of Alda-341 in Patients Undergoing Salivary Gland Surgery

The purpose of this study is determine salivary gland disposition of d-limonene, the primary component in citrus peel and a common dietary supplement. Salivary gland tissue and saliva will be collect...

Lead sponsor: Stanford University•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Trial snapshot

StatusCOMPLETED

PhaseEARLY_PHASE1

Enrollment10

Start dateFeb 2016

Last updatedMar 5, 2020

Condition

Submandibular Gland Tumor Parotid Gland Tumor

Locations shown

Stanford University

Stanford, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 5, 2020Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions